British Journal of Cancer, Published online: 04 April 2026; doi:10.1038/s41416-026-03420-2 Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer
British Journal of Cancer published a clinical update in Oncology on 04 Apr 2026.
The item focuses on Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.
Review the original article for the full source wording and details.